Intel vs AMD: The Ideal Long-Term Investment

Intel and AMD both posted Q1 2026 results, but AMD showed much stronger AI-driven momentum: revenue rose 37.9% to $10.253B, Data Center sales jumped 57% to $5.775B, and non-GAAP EPS beat estimates at $1.37. Intel’s revenue increased 7.2% to $13.6B, but the quarter included a $3.728B GAAP net loss tied to a $4.07B Mobileye impairment, even as Data Center and AI revenue grew 22% to $5.052B. AMD also guided Q2 revenue to about $11.2B, while Intel guided to $13.8B-$14.8B with just $0.20 non-GAAP EPS, keeping the market focused on AMD’s AI leverage versus Intel’s turnaround execution.

Analysis

The spread here is not just execution quality; it is capital efficiency. AMD is turning third-party wafer spend into operating leverage, which matters because AI demand is still bottlenecked by shipped capacity rather than end-demand. Intel, by contrast, is effectively asking the market to underwrite a multi-year industrial policy bet while its own margin structure remains too thin to self-fund the transition. That creates a timing mismatch: AMD monetizes the current AI cycle now, while Intel’s upside depends on a later-foundry payoff that the market is unlikely to reward until there is a credible external anchor customer.

Second-order, AMD’s momentum should continue to pressure both the accelerated-compute ecosystem and the memory stack. If MI450 stays on schedule, HBM suppliers and advanced packaging vendors become the quiet beneficiaries, while competitors without a clear shipping roadmap risk share leakage in hyperscaler procurement cycles. Intel’s foundry push could still matter strategically, but every incremental dollar of capex raises the hurdle for a reversal in sentiment; the longer the company stays in negative FCF, the more investors will treat any 18A/14A progress as a proof-of-concept rather than a monetizable franchise.

The main contrarian risk on AMD is that expectations are now high enough that a single-quarter slip in deployment timing or supply availability can compress the multiple quickly. Lisa Su’s insider selling does not invalidate the thesis, but it does suggest management sees upside as increasingly priced in. On Intel, the market may be underestimating how quickly a named external foundry customer could re-rate the story, because once a second logo arrives the debate shifts from “can they build?” to “how fast can they fill capacity?” That optionality is real, but it is a longer-dated catalyst than the stock currently deserves.

Key Decisions for Investors

• Stay long AMD on a 3-6 month horizon; use any post-earnings consolidation to add, targeting upside from continued AI shipment conversion, but respect a tighter stop if guidance credibility weakens or MI450 timing slips.
• Enter a tactical pair trade: long AMD / short INTC for the next 1-2 quarters, expressing the gap between monetized AI exposure and capex-heavy turnaround risk; this should work unless Intel announces a credible external foundry anchor.
• For Intel, keep only a starter position or optionality trade: buy longer-dated call spreads or small common stock exposure into 6-12 months, sized for a binary re-rating if 14A wins a named customer; downside is limited by sentiment, but thesis failure likely means dead money.
• Monitor TSM and HBM-linked suppliers as secondary beneficiaries over the next 1-2 quarters; AMD volume growth should be more directly transmitted to capacity and packaging bottlenecks than to near-term chip price competition.
• Avoid chasing AMD into strength without a catalyst window; the better entry is on pullbacks or after confirmation that the next product ramp is on schedule, since the stock is now more sensitive to execution slips than to macro AI optimism.